unknown
Stage
About
Edesa Biotech is a clinical-stage biopharmaceutical company developing host-directed monoclonal antibody therapies to treat immune and inflammatory diseases, including acute respiratory distress syndrome (ARDS).
Explore Edesa Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.